Audited Financial Results for the Quarter Ended 31st March, 2008.
Figures in Lacs (Indian Rupee)
Particulars For the Quarter Ended For the Quarter Ended For the Year Ended For the Year Ended Consolidated For the Year ended  Consolidated For the Year ended 
31st Mar.08 31st Mar.07 31st Mar.08 31st Mar.07 31st Mar.08 31st Mar.07
(Gross) Sales / Income from operations 11,922 8,226 33,585 31,330 33,661 32,110
Less : Excise Duty & Sales Tax 917 709 2512 3,079 2,425 3,162
(Net) Sales / Income from operations 11,005 7,515 31,073 28,251 31,236 28,949
Other Income 112 7 184 53 185 81
Total Expenditure 10,224 7,030 28,289 25,717 28,123 26,081
(a) Increase / Decrease in stock in trade
1,004 664 (924) 629 (1,038) 599
(b) Consumption of raw materials
4,776 4,299 18,259 17,255 18,541 18.141
(c) Staff cost
275 245 980 809 1,054 869
(d) Other expenditure
1,595 1,274 5,119 4,615 5,180 4,159
Interest 582 192 1,184 986 1,288 1,045
Depreciation 252 219 963 862 1,302 1,189
Profit Before Tax (PBT) 311 302 1,783 1,602 2,009 1,904
Provision for Tax 59 27 246 196 273 229
Profit After Tax (PAT) 252 275 1,537 1,406 1,737 1,675
Provision for Deferred Tax 65 10 230 129 256 198
Profit After Deferred Tax 187 264 1,307 1,277 1,481 1,477
Profit after Consolidation Adjustments. 187 264 1,307 1,277 1,374 1,378
Paid-up Equity Share Capital of Rs.10/- each. 1,171 1,171 1,171 1,171 1,171 1,171
Reserves & Surplus (excluding revaluation reserves) - - 9,734 8,674 9,982 8,841
Basic E P S (in Rs.) 1.60 2.25 11.17 10.91 11.73 11.77
Aggregate of Non Promoter Shareholding        
Number of Shares 6045866 5544125 6045866 5544125 6045866 5544125
Percentage of Total Shareholding 51.64 47.35 51.64 47.35 51.64 47.35
 
Notes :

There were no pending complaints at the beginning of the quarter. During the quarter one complaint was received and redressed. There were no complaints pending at the end of the quarter.

The figures of the previous periods have been regrouped and rearranged wherever necessary.

Company is operating as a single segment company, engaged in Pharmaceuticals business hence, the disclosure requirement as per AS-17 'Segment Reporting' is not attracted.

The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on 28th January, 2008.

 
  By order of the Board of Directors
FOR AARTI DRUGS LIMITED
Place : Mumbai
Date : 13th May, 2008.


Harshit M. Savla
(Jt. Managing Director )
 
 
 
Downloads
21st Annual Report 05 - 06    
20th Annual Report 04 - 05    
19th Annual Report 03 - 04    
   
 
Corporate Info | Product Profile | R & D Focus | Financials | Manufacturing | Export | Careers